A Win For ASLAN Pharmaceuticals Limited
Wed, Jan 04, 2023 at 07:00 PM
ASLAN Pharmaceuticals Limited (ASLN:NASDAQ) soared at $0.6, representing a gain of 37.7%. On Wed, Jan 04, 2023, ASLN:NASDAQ touched a New 2-Week High of $0.6. The stock appeared on our News Catalysts scanner on Tue, Jan 03, 2023 at 07:25 AM in the 'PATNERSHIP' category. From Wed, Dec 21, 2022, the stock recorded 37.50% Up Days and 33.33% Green Days
About ASLAN Pharmaceuticals Limited (ASLN:NASDAQ)
ASLAN Pharmaceuticals Ltd is an oncology-focused biotechnology company developing a portfolio of immuno-oncology agents and targeted therapies. Its products include Varlitinib, ASLAN002, ASLAN003, ASLAN004, ASLAN005, and Modybodies.
Top 10 Gainers:
- Vivos Therapeutics Inc. (VVOS:NASDAQ), 154.05%
- Cryptyde Inc. (TYDE:NASDAQ), 81.35%
- VYNE Therapeutics Inc. (VYNE:NASDAQ), 70.05%
- Shift Technologies Inc. (SFT:NASDAQ), 57.5%
- Relativity Acquisition Corp. (RACY:NASDAQ), 47.65%
- eFFECTOR Therapeutics Inc. (EFTR:NASDAQ), 44.9%
- Elys Game Technology Corp. (ELYS:NASDAQ), 39.96%
- Reunion Neuroscience Inc. (REUN:NASDAQ), 39.42%
- ASLAN Pharmaceuticals Limited (ASLN:NASDAQ), 37.72%
- Theseus Pharmaceuticals Inc. (THRX:NASDAQ), 36.28%